{"id":50012,"date":"2026-02-20T22:12:57","date_gmt":"2026-02-20T22:12:57","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/pharmaceutical-manufacturing-mordor\/"},"modified":"2026-09-25T04:24:31","modified_gmt":"2026-09-24T19:24:31","slug":"pharmaceutical-manufacturing-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/pharmaceutical-manufacturing-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc81c\uc57d \uc81c\uc870 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/pharmaceutical-manufacturing-1720087809998-pha.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/pharmaceutical-manufacturing-size-image-1770815103609.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \ub300\ud615 \uc81c\uc57d\uc0ac\uc758 R&amp;D \ud22c\uc790 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uae30\uc874 \uc0dd\uc0b0 \ub77c\uc778\uc5d0 AI \uae30\ubc18 \uc790\ub3d9\ud654 \ud1b5\ud569<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc8fc\uc694 \ud2b9\ud5c8 \ub9cc\ub8cc \ud6c4 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uae09\uc99d<\/li>\n<li class=\"toc-level-3\">4.2.4 API \uc0dd\uc0b0 \ub2a5\ub825\uc758 \ub9ac\uc1fc\uc5b4\ub9c1 \ubc0f \ud604\uc9c0\ud654<\/li>\n<li class=\"toc-level-3\">4.2.5 \ub9de\ucda4\ud615 \uc758\uc57d\ud488\uc744 \uc704\ud55c \ubd84\uc0b0\ud615 \uc18c\ub7c9 \ubc30\uce58 \ub77c\uc778<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc5f4 \ubc0f \uc6a9\ub9e4 \uc5c6\ub294 \uc815\uc81c 3D \ud504\ub9b0\ud305<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc804 \uc138\uacc4\uc801\uc778 \uc57d\uac00 \uc555\ub825 \ubc0f \ube44\uc6a9 \uc808\uac10<\/li>\n<li class=\"toc-level-3\">4.3.2 \ud575\uc2ec \ud22c\uc785\ubb3c \uacf5\uae09\ub9dd \ucde8\uc57d\uc131<\/li>\n<li class=\"toc-level-3\">4.3.3 GMP \ub4f1\uae09 \uc7ac\ud65c\uc6a9 \uc6a9\ub9e4 \ubd80\uc871<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc5f0\uacb0\ub41c \uacf5\uc7a5\uc758 \uc0ac\uc774\ubc84 \ubcf4\uc548 \ucc45\uc784<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.5 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.6 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778\n<ul>\n<li class=\"toc-level-3\">4.6.1 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.6.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.6.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \ubd84\uc790 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec<\/li>\n<li class=\"toc-level-3\">5.1.2 \uae30\uc874 \uc758\uc57d\ud488<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc81c\uc870 \ubc29\uc2dd\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc790\uccb4 \uc0dd\uc0b0<\/li>\n<li class=\"toc-level-3\">5.2.2 CMO \/ CDMO<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc81c\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc815\uc81c<\/li>\n<li class=\"toc-level-3\">5.3.2 \ucea1\uc290<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc8fc\uc0ac\uc81c<\/li>\n<li class=\"toc-level-3\">5.3.4 \uad6d\uc18c \ubc0f \uacbd\ud53c<\/li>\n<li class=\"toc-level-3\">5.3.5 \ube44\uac15 \ubc0f \ud3d0 \uc2a4\ud504\ub808\uc774<\/li>\n<li class=\"toc-level-3\">5.3.6 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc81c\uc870 \uae30\uc220\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubc30\uce58<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc5f0\uc18d<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc77c\ud68c\uc6a9<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc801\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \uc885\uc591\ud559<\/li>\n<li class=\"toc-level-3\">5.5.2 \ub2f9\ub1e8\ubcd1<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc2ec\ud608\uad00<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc2e0\uacbd\ud559<\/li>\n<li class=\"toc-level-3\">5.5.5 \ud638\ud761\uae30<\/li>\n<li class=\"toc-level-3\">5.5.6 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.6 \ucc98\ubc29 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.6.1 \ucc98\ubc29\uc57d<\/li>\n<li class=\"toc-level-3\">5.6.2 \uc77c\ubc18\uc758\uc57d\ud488 (OTC)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.7 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.7.1 \ubd81\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.7.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.7.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.7.1.3 \uba55\uc2dc\ucf54<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.7.2 \uc720\ub7fd\n<ul>\n<li class=\"toc-level-4\">5.7.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.7.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.7.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.7.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.7.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.7.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.7.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\n<ul>\n<li class=\"toc-level-4\">5.7.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.7.3.2 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.7.3.3 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.7.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.7.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.7.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.7.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74\n<ul>\n<li class=\"toc-level-4\">5.7.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.7.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.7.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-3\">5.7.5 \ub0a8\ubbf8\n<ul>\n<li class=\"toc-level-4\">5.7.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.7.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.7.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uc218\uc900 \uac1c\uc694, \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 \uc560\ube0c\ube44 Inc<\/li>\n<li class=\"toc-level-3\">6.3.2 \uc554\uc820<\/li>\n<li class=\"toc-level-3\">6.3.3 \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74 plc<\/li>\n<li class=\"toc-level-3\">6.3.4 BMS<\/li>\n<li class=\"toc-level-3\">6.3.5 \ubca0\ub9c1\uac70\uc778\uac94\ud558\uc784<\/li>\n<li class=\"toc-level-3\">6.3.6 \uce74\ud0c8\ub80c\ud2b8<\/li>\n<li class=\"toc-level-3\">6.3.7 \uc2dc\ud50c\ub77c<\/li>\n<li class=\"toc-level-3\">6.3.8 GSK plc<\/li>\n<li class=\"toc-level-3\">6.3.9 \ub9b4\ub9ac<\/li>\n<li class=\"toc-level-3\">6.3.10 \ub860\uc790<\/li>\n<li class=\"toc-level-3\">6.3.11 \uba38\ud06c &amp; Co<\/li>\n<li class=\"toc-level-3\">6.3.12 \ub178\ubc14\ud2f0\uc2a4<\/li>\n<li class=\"toc-level-3\">6.3.13 \ub178\ubcf4 \ub178\ub514\uc2a4\ud06c<\/li>\n<li class=\"toc-level-3\">6.3.14 \ud654\uc774\uc790 Inc<\/li>\n<li class=\"toc-level-3\">6.3.15 F. \ud638\ud504\ub9cc-\ub77c \ub85c\uc288 AG<\/li>\n<li class=\"toc-level-3\">6.3.16 \uc0ac\ub178\ud53c SA<\/li>\n<li class=\"toc-level-3\">6.3.17 \uc120 \ud30c\ub9c8<\/li>\n<li class=\"toc-level-3\">6.3.18 \ub2e4\ucf00\ub2e4<\/li>\n<li class=\"toc-level-3\">6.3.19 \ud14c\ubc14<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc758\uc57d\ud488 \uc81c\uc870 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21 (2026-2031)<\/p>\n<p>Mordor Intelligence\uc758 \ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, \uc758\uc57d\ud488 \uc81c\uc870 \uc2dc\uc7a5\uc740 \ubd84\uc790 \uc720\ud615, \uc81c\uc870 \ubc29\uc2dd, \uc81c\ud615, \uc81c\uc870 \uae30\uc220, \uc801\uc6a9 \ubd84\uc57c, \ucc98\ubc29 \uc720\ud615 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \uc788\uc73c\uba70, \uc2dc\uc7a5 \uac00\uce58\ub294 USD \uae30\uc900\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \uc218\uce58<\/p>\n<p>\uc758\uc57d\ud488 \uc81c\uc870 \uc2dc\uc7a5\uc740 2025\ub144 5,065\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 5,554\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \ucd94\uc815\ub418\uba70, 2031\ub144\uc5d0\ub294 8,852\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\uc5ec \uc608\uce21 \uae30\uac04(2026-2031) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 9.77%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc740 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774\uba70, \ubd81\ubbf8\uac00 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc744 \ud615\uc131\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 &#8216;\uc911\uac04&#8217; \uc218\uc900\uc785\ub2c8\ub2e4.<\/p>\n<p>\ucd5c\uadfc \uc758\uc57d\ud488 \uc81c\uc870 \uc0b0\uc5c5\uc740 \uc5f0\uc18d \uc0dd\uc0b0, \uc77c\ud68c\uc6a9 \uc2dc\uc2a4\ud15c, AI \uae30\ubc18 \uc0dd\uc0b0 \ub77c\uc778\uc73c\ub85c\uc758 \uc804\ud658\uc744 \ud1b5\ud574 \uc0dd\uc0b0 \uc8fc\uae30 \ub2e8\ucd95, \ubd88\ub7c9\ub960 \uac10\uc18c, \uaddc\uc81c \uc2b9\uc778 \ud14c\uc2a4\ud2b8\uc758 \uc0c1\ub958 \uc774\ub3d9\uc744 \uc2e4\ud604\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144\ubd80\ud130 2026\ub144 \ucd08\uae4c\uc9c0 3\ucc9c\uc5b5 \ub2ec\ub7ec \uc774\uc0c1\uc758 \uc2e0\uaddc \ubc0f \uae30\uc874 \uc2dc\uc124 \ud22c\uc790\uac00 \uc774\ub8e8\uc5b4\uc84c\uc73c\uba70, Eli Lilly\uc758 270\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8 \ub2e4\uc911 \uc2dc\uc124 \uad6c\ucd95\uacfc AstraZeneca\uc758 500\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8 \ubc14\uc774\uc624\uc758\uc57d\ud488 \ud22c\uc790\uac00 \uc774\ub97c \uc8fc\ub3c4\ud588\uc2b5\ub2c8\ub2e4. \ubbf8\uad6d FDA\uc758 2024\ub144 FRAME \uc774\ub2c8\uc154\ud2f0\ube0c\ub294 \uc2e4\uc2dc\uac04 \ucd9c\uc2dc \ud14c\uc2a4\ud2b8\ub97c \uc2dc\uc124 \uac80\ud1a0\uc5d0 \ud1b5\ud569\ud558\uc5ec \uc801\uaca9 \uc2a4\ud3f0\uc11c\uc758 \uc2dc\uc7a5 \ucd9c\uc2dc \uc2dc\uac04\uc744 \ucd5c\ub300 2\ub144 \ub2e8\ucd95\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc2b9\uc778, API(\uc6d0\ub8cc\uc758\uc57d\ud488) \ud604\uc9c0\ud654 \ud504\ub85c\uadf8\ub7a8, AI \ucd5c\uc801\ud654\ub41c \uae30\uc874 \ub77c\uc778\ub4e4\uc774 \uacb0\ud569\ud558\uc5ec \uc758\uc57d\ud488 \uc81c\uc870 \uc2dc\uc7a5\uc744 \uacfc\uac70 10\ub144\ubcf4\ub2e4 \uad6c\uc870\uc801\uc73c\ub85c \ub354 \ub192\uc740 \uc131\uc7a5 \uacbd\ub85c\ub85c \uc774\ub04c\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>*   \ubd84\uc790 \uc720\ud615\ubcc4: 2025\ub144 \ub9e4\ucd9c\uc758 55.55%\ub97c \ucc28\uc9c0\ud55c \uc804\ud1b5 \uc758\uc57d\ud488\uc774 \uc120\ub450\ub97c \uc720\uc9c0\ud588\uc73c\ub098, \ubc14\uc774\uc624\uc758\uc57d\ud488 \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\ub294 2031\ub144\uae4c\uc9c0 10.85%\uc758 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc81c\uc870 \ubc29\uc2dd\ubcc4: 2025\ub144 \uc0dd\uc0b0\ub7c9\uc758 61.53%\ub97c \uc704\ud0c1\uc0dd\uc0b0\uac1c\ubc1c\uae30\uad00(CMO\/CDMO)\uc774 \ucc28\uc9c0\ud588\uc73c\ub098, \uc790\uccb4 \uc0dd\uc0b0(In-House) \ub77c\uc778\uc740 2031\ub144\uae4c\uc9c0 11.75%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc81c\ud615\ubcc4: 2025\ub144 \ub9e4\ucd9c\uc758 39.15%\ub97c \uc815\uc81c\uac00 \ucc28\uc9c0\ud588\uc73c\uba70, \uc8fc\uc0ac\uc81c\ub294 GLP-1 \ubc0f CAR-T \uc218\uc694\uc5d0 \ud798\uc785\uc5b4 10.83%\uc758 CAGR\ub85c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc81c\uc870 \uae30\uc220\ubcc4: 2025\ub144 \uc9c0\ucd9c\uc758 71.52%\ub97c \ubc30\uce58(Batch) \uacf5\uc815\uc774 \ucc28\uc9c0\ud588\uc73c\ub098, \uc5f0\uc18d(Continuous) \ud50c\ub7ab\ud3fc\uc740 2031\ub144\uae4c\uc9c0 12.15%\uc758 CAGR\ub85c \ud655\uc7a5\ub420 \uac83\uc785\ub2c8\ub2e4.<br \/>\n*   \uc801\uc6a9 \ubd84\uc57c\ubcc4: 2025\ub144 \ub9e4\ucd9c\uc758 28.55%\ub97c \uc885\uc591\ud559 \uce58\ub8cc\uc81c\uac00 \ucc28\uc9c0\ud588\uc73c\uba70, \uc2e0\uacbd\ud559\uc740 2031\ub144\uae4c\uc9c0 12.72%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \ubd80\ubb38\uc785\ub2c8\ub2e4.<br \/>\n*   \ucc98\ubc29 \uc720\ud615\ubcc4: 2025\ub144 \uc0dd\uc0b0\ub7c9\uc758 82.62%\ub97c \ucc98\ubc29 \uc758\uc57d\ud488\uc774 \ucc28\uc9c0\ud588\uc73c\uba70, \uc77c\ubc18\uc758\uc57d\ud488(OTC)\uc740 2031\ub144\uae4c\uc9c0 10.82%\uc758 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: 2025\ub144 \ubd81\ubbf8\uac00 \ub9e4\ucd9c\uc758 28.15%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\uc740 2026-2031\ub144 \ub3d9\uc548 10.66%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<\/p>\n<p>\uae00\ub85c\ubc8c \uc758\uc57d\ud488 \uc81c\uc870 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p>\uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825 (Drivers)<\/p>\n<p>*   \ub300\ud615 \uc81c\uc57d\uc0ac\uc758 R&#038;D \ud22c\uc790 \uc99d\uac00 (+2.1% CAGR \uc601\ud5a5): 2025\ub144 \uae00\ub85c\ubc8c \uc81c\uc57d R&#038;D \uc9c0\ucd9c\uc740 1,900\uc5b5 \ub2ec\ub7ec\uc5d0 \ub2ec\ud588\uc73c\uba70, \uc774 \uc911 22%\uac00 \uc81c\uc870 \uacfc\ud559\uc5d0 \ud560\ub2f9\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc2a4\ud3f0\uc11c\ub4e4\uc740 IND(\uc784\uc0c1\uc2dc\ud5d8\uacc4\ud68d) \ub2e8\uacc4\ubd80\ud130 \uc5f0\uc18d \uc81c\uc870 \uac00\ub2a5\uc131\uc744 \uacc4\ud68d\ud558\uc5ec \uacf5\uc815 \uac1c\ubc1c\uacfc \uc2a4\ucf00\uc77c\uc5c5 \uac04\uc758 \uaca9\ucc28\ub97c \uc904\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. Eli Lilly\uc640 AstraZeneca\uc758 \ub300\uaddc\ubaa8 \ud22c\uc790\ub294 \uc2e0\uaddc \ubd84\uc790 \uc5d4\ud2f0\ud2f0 \ub3c4\uc785 \ubc0f \ub2e4\uc591\ud55c \uce58\ub8cc\ubc95 \uac04 \uc804\ud658 \ub2a5\ub825\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2025\ub144 FDA\ub294 38\uac74\uc758 \uc2e0\ud765 \uae30\uc220 \uc9c0\uc815\uc744 \ud1b5\ud574 \ubc30\uce58 \ucd9c\uc2dc \uc8fc\uae30\ub97c 30\uc77c\uc5d0\uc11c 5\uc77c \ubbf8\ub9cc\uc73c\ub85c \ub2e8\ucd95\uc2dc\ucf30\uc2b5\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \uc790\ub3d9\ud654\uc758 \uae30\uc874 \ub77c\uc778 \ud1b5\ud569 (+1.8% CAGR \uc601\ud5a5): AI \uae30\ubc18 \uacf5\uc815 \ubd84\uc11d \uae30\uc220(PAT)\uc740 \uc804 \uc138\uacc4 \uc0dd\uc0b0 \ub77c\uc778\uc758 28%\uc5d0 \uc801\uc6a9\ub418\uc5b4 \ubd88\ub7c9 \ubc30\uce58\uc728\uc744 19% \uac10\uc18c\uc2dc\ud0a4\uace0 \uc804\uccb4 \uc7a5\ube44 \ud6a8\uc728\uc131\uc744 14% \ud5a5\uc0c1\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. 2024\ub144 FDA \uc9c0\uce68\uc740 \uac80\uc99d\ub41c \uba38\uc2e0\ub7ec\ub2dd \ubaa8\ub378\uc774 \ucd5c\uc885 \uc81c\ud488 \ud14c\uc2a4\ud2b8\ub97c \uacf5\uc815 \ub0b4 \ubd84\uad11\ubc95\uc73c\ub85c \ub300\uccb4\ud560 \uc218 \uc788\ub3c4\ub85d \ud5c8\uc6a9\ud558\uc5ec \ubd84\uc11d \ube44\uc6a9\uc744 \uc808\uac10\ud569\ub2c8\ub2e4. Novo Nordisk\ub294 GLP-1 \ucda9\uc804-\uc644\ub8cc \ub77c\uc778\uc758 \uc804\ud658 \uc2dc\uac04\uc744 40% \ub2e8\ucd95\ud588\uc73c\uba70, \uc601\uad6d MHRA\uc758 \ub514\uc9c0\ud138 \ud2b8\uc708 \ud30c\uc77c\ub7ff\uc740 \uac00\uc0c1 \uac80\uc99d \ud328\ud0a4\uc9c0 \uc81c\ucd9c\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \uc8fc\uc694 \ud2b9\ud5c8 \ub9cc\ub8cc \ud6c4 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uae09\uc99d (+2.3% CAGR \uc601\ud5a5): 2024\ub144\uc5d0\uc11c 2026\ub144 \uc0ac\uc774\uc5d0 11\uac1c \ube14\ub85d\ubc84\uc2a4\ud130 \ubc14\uc774\uc624\uc758\uc57d\ud488 \ud2b9\ud5c8 \ub9cc\ub8cc\ub85c \uc5f0\uac04 680\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uc2dc\uc7a5\uc774 \uc5f4\ub838\uace0, 2025\ub144 \uc911\ubc18\uae4c\uc9c0 23\uac74\uc758 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc2b9\uc778\uc774 \uc774\ub8e8\uc5b4\uc84c\uc2b5\ub2c8\ub2e4. \uc0bc\uc131\ubc14\uc774\uc624\ub85c\uc9c1\uc2a4\ub294 8\uac1c\uc758 \uc2e0\uaddc \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uacc4\uc57d\uc744 \uc704\ud574 \uc778\ucc9c\uc5d0 36\ub9cc \ub9ac\ud130\uc758 \ubc14\uc774\uc624\ub9ac\uc561\ud130 \uc6a9\ub7c9\uc744 \ucd94\uac00\ud588\uc2b5\ub2c8\ub2e4. \uc720\ub7fd\uc740 2025\ub144 \uc801\uaca9 \ubc14\uc774\uc624\uc758\uc57d\ud488 \ucc98\ubc29\uc758 47%\uc5d0 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uac00 \uce68\ud22c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   API \uc0dd\uc0b0 \ub2a5\ub825\uc758 \uad6d\ub0b4 \ubcf5\uadc0 \ubc0f \ud604\uc9c0\ud654 (+1.6% CAGR \uc601\ud5a5): \ubbf8\uad6d BARDA\ub294 14\uac1c \ud575\uc2ec API\uc758 \uad6d\ub0b4 \ubcf5\uadc0\ub97c \uc704\ud574 2024-2025\ub144\uc5d0 12\uc5b5 \ub2ec\ub7ec\ub97c \ud22c\uc790\ud588\uc73c\uba70, EU\uc758 Critical Medicines Act\ub294 \uc5ed\ub0b4 \uc0dd\uc0b0\uc5d0 25%\uc758 \uc790\ubcf8 \uc9c0\ucd9c \uc138\uc561 \uacf5\uc81c\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc778\ub3c4\uc758 PLI \uc81c\ub3c4\ub294 2025\ub144\uae4c\uc9c0 20\uc5b5 \ub2ec\ub7ec\ub97c \uc9c0\uae09\ud558\uc5ec 2028\ub144\uae4c\uc9c0 \ud575\uc2ec \uc6d0\ub8cc \uc790\uae09\ub960\uc744 35%\ub85c \ub192\uc774\ub294 \uac83\uc744 \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4. Pfizer\ub294 15\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \ub178\uc2a4\uce90\ub864\ub77c\uc774\ub098 \uc2dc\uc124\uc744 \ud1b5\ud574 \uc544\uc2dc\uc544\uc5d0 \uc544\uc6c3\uc18c\uc2f1\ub418\ub358 9\uac1c \ubd84\uc790\ub97c \ud1b5\ud569\ud560 \uc608\uc815\uc785\ub2c8\ub2e4.<br \/>\n*   \uac1c\uc778 \ub9de\ucda4\ud615 \uc758\uc57d\ud488\uc744 \uc704\ud55c \ubd84\uc0b0\ud615 \ub9c8\uc774\ud06c\ub85c \ubc30\uce58 \ub77c\uc778 (+1.2% CAGR \uc601\ud5a5) \ubc0f \uc815\uc81c \uc5f4\/\uc6a9\ub9e4 \uc5c6\ub294 3D \ud504\ub9b0\ud305 (+0.9% CAGR \uc601\ud5a5) \ub610\ud55c \uc7a5\uae30\uc801\uc778 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc81c\uc57d \uc694\uc778 (Restraints)<\/p>\n<p>*   \uae00\ub85c\ubc8c \uc57d\uac00 \uc555\ub825 \ubc0f \ube44\uc6a9 \uc808\uac10 (-1.9% CAGR \uc601\ud5a5): \uba54\ub514\ucf00\uc5b4\uc758 2026\ub144 \uace0\uc9c0\ucd9c \uc758\uc57d\ud488 10\uac1c\uc5d0 \ub300\ud55c \uac00\uaca9 \uc0c1\ud55c\uc81c\ub294 2031\ub144\uae4c\uc9c0 \uc5c5\uacc4 \ub9e4\ucd9c\uc5d0\uc11c 400\uc5b5 \ub2ec\ub7ec\ub97c \uac10\uc18c\uc2dc\ud0ac \uac83\uc774\uba70, \ubc14\uc774\uc624\uc758\uc57d\ud488\uc774 \uc774 \uc911 60%\ub97c \ucc28\uc9c0\ud560 \uac83\uc785\ub2c8\ub2e4. \uc720\ub7fd\uc758 2024\ub144 HTA \uac1c\ud601\uc740 \uc0c1\ud658 \ud611\uc0c1 \uae30\uac04\uc744 270\uc77c\ub85c \uc5f0\uc7a5\ud558\uc5ec \uc2e0\uaddc \ucd9c\uc2dc \uc81c\ud488\uc758 \uc21c\ud604\uc7ac\uac00\uce58\ub97c 12% \ud558\ub77d\uc2dc\ucf30\uc2b5\ub2c8\ub2e4. \uc2a4\ud3f0\uc11c\ub4e4\uc740 \uac00\uaca9 \uc555\ubc15\uc744 \uc0c1\uc1c4\ud558\uae30 \uc704\ud574 \uc5f0\uc18d \uacf5\uc815\uc73c\ub85c \uc804\ud658\ud558\uace0 \uc788\uc73c\ub098, \uac01 \ub77c\uc778\ub2f9 5\ucc9c\ub9cc~8\ucc9c\ub9cc \ub2ec\ub7ec\uc758 \ucd08\uae30 \uc790\ubcf8\uc774 \ud544\uc694\ud569\ub2c8\ub2e4.<br \/>\n*   \ud575\uc2ec \ud22c\uc785\ubb3c \uacf5\uae09\ub9dd \ucde8\uc57d\uc131 (-1.4% CAGR \uc601\ud5a5): 2024\ub144 FDA\ub294 137\uac74\uc758 \ud65c\uc131 \uc758\uc57d\ud488 \ubd80\uc871 \uc0ac\ud0dc\ub97c \ucd94\uc801\ud588\uc73c\uba70, \uc774 \uc911 62%\uac00 \uc911\uad6d \ubc0f \uc778\ub3c4 API \uacf5\uc7a5\uc758 \ucc28\uc9c8\uacfc \uad00\ub828\uc774 \uc788\uc5c8\uc2b5\ub2c8\ub2e4. GLP-1 \uc218\uc694 \uae09\uc99d\uc73c\ub85c \ubd95\uaddc\uc0b0 \ubc14\uc774\uc54c\uc758 \ub9ac\ub4dc \ud0c0\uc784\uc774 26\uc8fc\ub85c \ub450 \ubc30 \uc99d\uac00\ud588\uc2b5\ub2c8\ub2e4. \uae30\uc5c5\ub4e4\uc740 2025\ub144 \uc548\uc804 \uc7ac\uace0\ub97c 75\uc77c\ub85c \ub298\ub824 \uc5c5\uacc4 \uc804\ubc18\uc5d0 \uac78\uccd0 80\uc5b5 \ub2ec\ub7ec\uc758 \ucd94\uac00 \uc6b4\uc804\uc790\ubcf8\uc744 \ubb36\uc5c8\uc2b5\ub2c8\ub2e4.<br \/>\n*   GMP \ub4f1\uae09 \uc7ac\ud65c\uc6a9 \uc6a9\ub9e4 \ubd80\uc871 (-0.8% CAGR \uc601\ud5a5)\uacfc \uc5f0\uacb0\ub41c \uacf5\uc7a5\uc758 \uc0ac\uc774\ubc84 \ubcf4\uc548 \ucc45\uc784 (-1.1% CAGR \uc601\ud5a5) \ub610\ud55c \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>*   \ubd84\uc790 \uc720\ud615\ubcc4: \ubc14\uc774\uc624\uc758\uc57d\ud488, \uc790\ubcf8 \ubc30\ubd84 \uc7ac\ud3b8<br \/>\n    \ubc14\uc774\uc624\uc758\uc57d\ud488 \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\ub294 \ube14\ub85d\ubc84\uc2a4\ud130 \ud56d\uccb4 \ud2b9\ud5c8 \ub9cc\ub8cc\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 10.85%\uc758 CAGR\ub85c \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud560 \uac83\uc785\ub2c8\ub2e4. \uc804\ud1b5 \uc758\uc57d\ud488\uc740 2025\ub144 \ub9e4\ucd9c\uc758 55.55%\ub97c \ucc28\uc9c0\ud588\uc9c0\ub9cc, \uc778\ud50c\ub808\uc774\uc158 \uac10\ucd95\ubc95(IRA)\uc5d0 \ub530\ub978 \uac00\uaca9 \uc555\ubc15\uc73c\ub85c \uc804\ub9dd\uc774 \uc81c\ud55c\uc801\uc785\ub2c8\ub2e4. \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \ucd9c\uc2dc\uc5d0 \ub530\ub978 \uc2dc\uc7a5 \uaddc\ubaa8\ub294 2025\ub144 220\uc5b5 \ub2ec\ub7ec\uc5d0 \ub2ec\ud588\uc73c\uba70, \uc0bc\uc131\ubc14\uc774\uc624\ub85c\uc9c1\uc2a4\uc640 Lonza\uc758 \uc0dd\uc0b0 \ub2a5\ub825 \uc99d\ub300\ub97c \uc774\ub04c\uc5c8\uc2b5\ub2c8\ub2e4. \uc18c\ubd84\uc790 \uacf5\uc7a5\uc740 FDA ICH Q13 \uc5f0\uc18d \uacf5\uc815 \uc9c0\uce68\uc758 \ud61c\ud0dd\uc744 \ubc1b\ub294 \ubc18\uba74, \ubc14\uc774\uc624\uc758\uc57d\ud488 \ub77c\uc778\uc740 \ucf5c\ub4dc\uccb4\uc778 \ubc0f \ube44\uad50 \uac00\ub2a5\uc131 \ubb38\uc81c\ub85c \uc778\ud574 \uc120\ub3c4\uc801\uc778 CDMO\uc5d0 \uc2dc\uc7a5 \uc810\uc720\uc728\uc774 \uc9d1\uc911\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc81c\uc870 \ubc29\uc2dd\ubcc4: \uc790\uccb4 \uc0dd\uc0b0 \ub77c\uc778, \ubaa8\uba58\ud140 \ud655\ubcf4<br \/>\n    \uc2a4\ud3f0\uc11c\ub4e4\uc774 \uace0\ubd80\uac00\uac00\uce58 \uc790\uc0b0\uc744 \uc790\uccb4 \uc0dd\uc0b0\uc73c\ub85c \uc804\ud658\ud558\uba74\uc11c \uc790\uccb4 \uc0dd\uc0b0(In-House)\uc740 11.75%\uc758 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. CDMO\uac00 2025\ub144 \uc0dd\uc0b0\ub7c9\uc758 61.53%\ub97c \ucc28\uc9c0\ud588\uc74c\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0, Eli Lilly\uc640 Pfizer\uc758 \ub300\uaddc\ubaa8 \ud655\uc7a5\uc740 \ud32c\ub370\ubbf9 \uc2dc\ub300\uc758 \ud63c\ub780 \uc774\ud6c4 \ud1b5\uc81c\uc5d0 \ub300\ud55c \uc774\uc0ac\ud68c \uc218\uc900\uc758 \uc758\uc9c0\ub97c \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc5f0\uac04 \ub9e4\ucd9c 20\uc5b5 \ub2ec\ub7ec\ub97c \ucd08\uacfc\ud558\ub294 \ube14\ub85d\ubc84\uc2a4\ud130 \ubc14\uc774\uc624\uc758\uc57d\ud488\uc758 \uacbd\uc6b0, \uc790\uccb4 \uacf5\uc7a5\uc740 CDMO \uc218\uc218\ub8cc \uce68\uc2dd\uc744 15-20% \ud53c\ud558\uace0 IP \uc720\ucd9c \uc704\ud5d8\uc744 \uc904\uc785\ub2c8\ub2e4. CDMO\ub294 CAR-T \ubc0f mRNA\uc640 \uac19\uc740 \ubcf5\uc7a1\ud55c \ubd84\uc57c\ub85c \uc804\ud658\ud558\uc5ec \ud504\ub9ac\ubbf8\uc5c4 \ub2e4\ub144 \uacc4\uc57d\uc744 \ud655\ubcf4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. FDA\uc758 \ucca8\ub2e8 \uc81c\uc870 \uae30\uc220 \ud504\ub85c\uadf8\ub7a8\uc740 \uc5f0\uc18d \ubc0f \uc77c\ud68c\uc6a9 \uc2dc\uc2a4\ud15c\uc744 \ucc44\ud0dd\ud558\ub294 CDMO\uc640 \uc790\uccb4 \uc0dd\uc0b0 \uc2a4\ud3f0\uc11c \ubaa8\ub450\uc5d0\uac8c \ud61c\ud0dd\uc744 \uc81c\uacf5\ud558\uc5ec \uc5ed\ub3d9\uc801\uc778 \uacbd\uc7c1 \ud658\uacbd\uc744 \uc720\uc9c0\ud569\ub2c8\ub2e4.<\/p>\n<p>*   \uc81c\ud615\ubcc4: \uc8fc\uc0ac\uc81c, \ubc14\uc774\uc624\uc758\uc57d\ud488 \ubb3c\uacb0 \ud3ec\ucc29<br \/>\n    \uc815\uc81c\ub294 2025\ub144 \ub9e4\ucd9c\uc758 39.15%\ub97c \ucc28\uc9c0\ud588\uc9c0\ub9cc, \uc8fc\uc0ac\uc81c\ub294 \ubc14\uc774\uc624\uc758\uc57d\ud488, GLP-1, \ud56d\uc554 \uce58\ub8cc\uc81c \uc218\uc694 \uc99d\uac00\uc5d0 \ud798\uc785\uc5b4 10.83%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc8fc\uc0ac\uc81c \uc2dc\uc7a5\uc740 \uc9c0\uc18d\uc801\uc778 \ubc14\uc774\uc54c \ubc0f \ub9c8\uac1c \ubd80\uc871\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \ud655\uc7a5\ub418\uace0 \uc788\uc73c\uba70, \uc774\ub294 \ub9ac\ub4dc \ud0c0\uc784\uc744 6\uac1c\uc6d4\ub85c \ub298\ub9ac\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uacbd\uad6c\uc6a9 \uace0\ud615 \uc81c\ud615 \uae30\uc220\uc740 Aprecia\uc758 FDA \uc2b9\uc778 Spritam \ubcf5\uc6a9\ub7c9 \ud655\uc7a5\uacfc \uac19\uc740 3D \ud504\ub9b0\ud305\uc744 \ud1b5\ud574 \ubc1c\uc804\ud558\uace0 \uc788\uc9c0\ub9cc, \ub290\ub9b0 \ucc98\ub9ac\ub7c9\uacfc \ub178\uc990 \uc720\uc9c0 \ubcf4\uc218 \ube44\uc6a9\uc73c\ub85c \uc778\ud574 \ucc44\ud0dd\uc774 \uc2e0\uacbd\ud559 \ubd84\uc57c\uc5d0 \uad6d\ud55c\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc81c\uc870 \uae30\uc220\ubcc4: \uc5f0\uc18d \uc0dd\uc0b0 \ub77c\uc778, \ubc30\uce58 \uc0dd\uc0b0 \uc9c0\ubc30\ub825 \uae68\ub728\ub824<br \/>\n    \ubc30\uce58 \uc2dc\uc2a4\ud15c\uc740 2025\ub144 \uc9c0\ucd9c\uc758 71.52%\ub97c \ucc28\uc9c0\ud588\uc9c0\ub9cc, \uc5f0\uc18d \uc0dd\uc0b0 \ub77c\uc778\uc740 \ub2e8\uc704\ub2f9 \ube44\uc6a9\uc744 20-30% \uc808\uac10\ud558\uace0 \ucd9c\uc2dc \ud14c\uc2a4\ud2b8\ub97c \uac00\uc18d\ud654\ud558\uc5ec 12.15%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\uc744 \uae30\ub85d\ud588\uc2b5\ub2c8\ub2e4. 2025\ub144 FDA\uc758 38\uac1c \uc2e0\ud765 \uae30\uc220 \uc9c0\uc815 \uc911 22\uac1c\uac00 \ub0b4\uc7a5\ub41c \uc644\uc804 \uc5f0\uc18d \ud50c\ub7ab\ud3fc\uc744 \uc9c0\uc6d0\ud588\uc2b5\ub2c8\ub2e4. 2025\ub144 \ubc14\uc774\uc624\ub9ac\uc561\ud130 \uc124\uce58\uc758 68%\uc5d0 \uc0ac\uc6a9\ub41c \uc77c\ud68c\uc6a9 \ud558\ub4dc\uc6e8\uc5b4\ub294 \uc138\ucc99 \uac80\uc99d \ubc0f \ub2e4\uc6b4\ud0c0\uc784\uc744 \uc904\uc5ec \ubc30\uce58 \ubc0f \uc5f0\uc18d \ubc14\uc774\uc624\uc758\uc57d\ud488 \uc0dd\uc0b0\uc744 \ubaa8\ub450 \uc9c0\uc6d0\ud569\ub2c8\ub2e4. Vertex\ub294 \ub450 \uac1c\uc758 \ubc30\uce58 \ub77c\uc778\uc744 \uc5f0\uc18d \uc6b4\uc601\uc73c\ub85c \uc804\ud658\ud558\uc5ec \ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d \ud504\ub79c\ucc28\uc774\uc988\uc758 \ub9ac\ub4dc \ud0c0\uc784\uc744 \uc808\ubc18\uc73c\ub85c \uc904\uc600\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc801\uc6a9 \ubd84\uc57c\ubcc4: \uc2e0\uacbd\ud559 \uce58\ub8cc\uc81c, \uc804\ubb38 \uc0dd\uc0b0 \ub2a5\ub825 \uc8fc\ub3c4<br \/>\n    \uc2e0\uacbd\ud559\uc740 \uc54c\uce20\ud558\uc774\uba38 \ud56d\uccb4(Kisunla, Leqembi) \ubc0f SMA, DMD \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 12.72%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc801\uc6a9 \ubd84\uc57c\uc785\ub2c8\ub2e4. 2025\ub144 \ub9e4\ucd9c\uc758 28.55%\ub97c \ucc28\uc9c0\ud55c \uc885\uc591\ud559\uc740 \uaddc\ubaa8 \uba74\uc5d0\uc11c \uc120\ub450\ub97c \uc720\uc9c0\ud558\uc9c0\ub9cc, \ucd08\uac15\ub825 \ud654\ud569\ubb3c\uc740 5\ub9c8\uc774\ud06c\ub85c\uadf8\ub7a8 \ubbf8\ub9cc\uc758 \ubd09\uc1c4\ub97c \uc694\uad6c\ud558\uc5ec \uaddc\uc815 \uc900\uc218 \uc608\uc0b0\uc744 \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4. Eli Lilly\ub294 270\uc5b5 \ub2ec\ub7ec \ud655\uc7a5 \ud22c\uc790\uc758 40%\ub97c \uc8fc\uc785 \uc13c\ud130 \uadfc\ucc98\uc758 \uc2e0\uacbd\ud559 \ubc0f \uc885\uc591\ud559 \uc2a4\uc704\ud2b8\uc5d0 \ud560\ub2f9\ud588\uc73c\uba70, Novartis\uc640 Gilead\uc758 CAR-T \ud30c\uc77c\ub7ff\uc740 \ubd84\uc0b0\ud615 \ub178\ub4dc\uc758 \uc774\uc810\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<\/p>\n<p>*   \ucc98\ubc29 \uc720\ud615\ubcc4: OTC, \uc790\uac00 \uce58\ub8ccOTC(\uc77c\ubc18\uc758\uc57d\ud488) \ubc0f \uc790\uac00 \uce58\ub8cc\ub294 \uc18c\ube44\uc790\uac00 \uc758\uc0ac\uc758 \ucc98\ubc29 \uc5c6\uc774 \uc9c1\uc811 \uad6c\ub9e4\ud558\uace0 \uc0ac\uc6a9\ud560 \uc218 \uc788\ub294 \uc758\uc57d\ud488 \ubc0f \uac74\uac15 \uad00\ub9ac \uc194\ub8e8\uc158\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4. \uc774 \ubd84\uc57c\ub294 \ud3b8\uc758\uc131, \uc811\uadfc\uc131, \uadf8\ub9ac\uace0 \uac1c\uc778 \uac74\uac15 \uad00\ub9ac\uc5d0 \ub300\ud55c \uc18c\ube44\uc790\uc758 \uad00\uc2ec \uc99d\uac00\uc5d0 \ud798\uc785\uc5b4 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788, \uacbd\ubbf8\ud55c \uc9c8\ud658\uc758 \uad00\ub9ac\ub098 \ub9cc\uc131 \uc9c8\ud658\uc758 \ubcf4\uc870\uc801 \uce58\ub8cc\ub97c \uc704\ud55c \uc790\uac00 \uce58\ub8cc\uc758 \uc911\uc694\uc131\uc774 \ubd80\uac01\ub418\uba74\uc11c, \uc81c\uc57d\uc0ac\ub4e4\uc740 \ucc98\ubc29\uc57d(Rx)\uc744 \uc77c\ubc18\uc758\uc57d\ud488(OTC)\uc73c\ub85c \uc804\ud658(Rx-to-OTC switch)\ud558\uac70\ub098, \uc18c\ube44\uc790\uac00 \uc9c1\uc811 \uc0ac\uc6a9\ud560 \uc218 \uc788\ub294 \ud601\uc2e0\uc801\uc778 \uc81c\ud488 \uac1c\ubc1c\uc5d0 \uc8fc\ub825\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ub300\ub7c9 \uc0dd\uc0b0 \ub2a5\ub825, \uc0ac\uc6a9\uc790 \uce5c\ud654\uc801\uc778 \ud3ec\uc7a5 \ubc0f \uc81c\ud615 \uac1c\ubc1c, \uadf8\ub9ac\uace0 \uc9c1\uc811\uc801\uc778 \uc18c\ube44\uc790 \ub9c8\ucf00\ud305 \uc804\ub7b5\uc758 \uc911\uc694\uc131\uc744 \uc99d\ub300\uc2dc\ud0a4\uba70, \uc81c\uc57d \uc0b0\uc5c5\uc758 \uc0c8\ub85c\uc6b4 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \ubcd1\uc6d0, \uc57d\uad6d, \uc628\ub77c\uc778 \uc57d\uad6d<br \/>\n    \ucd5c\uc885 \uc0ac\uc6a9\uc790 \ubd80\ubb38\uc740 \uc758\uc57d\ud488\uc774 \uc18c\ube44\uc790\uc5d0\uac8c \ub3c4\ub2ec\ud558\ub294 \ub2e4\uc591\ud55c \uacbd\ub85c\ub97c \ubc18\uc601\ud569\ub2c8\ub2e4. \ubcd1\uc6d0\uc740 \uc785\uc6d0 \ud658\uc790 \ubc0f \uc678\ub798 \ud658\uc790 \uce58\ub8cc\ub97c \uc704\ud55c \uc758\uc57d\ud488\uc758 \uc8fc\uc694 \uc18c\ube44\ucc98\uc774\uba70, \ubcf5\uc7a1\ud55c \uce58\ub8cc \ubc0f \uc218\uc220 \ud6c4 \uad00\ub9ac\uc5d0 \ud544\uc694\ud55c \uc804\ubb38 \uc758\uc57d\ud488 \uc218\uc694\ub97c \uc8fc\ub3c4\ud569\ub2c8\ub2e4. \uc57d\uad6d\uc740 \uc77c\ubc18\uc758\uc57d\ud488(OTC) \ubc0f \ucc98\ubc29\uc57d(Rx)\uc744 \ubaa8\ub450 \uc81c\uacf5\ud558\uba70, \uc9c0\uc5ed \uc0ac\ud68c\uc5d0\uc11c \ud658\uc790\uc5d0\uac8c \uc9c1\uc811 \uc758\uc57d\ud488\uc744 \uacf5\uae09\ud558\ub294 \ud575\uc2ec\uc801\uc778 \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4. \ucd5c\uadfc\uc5d0\ub294 \uc628\ub77c\uc778 \uc57d\uad6d\uc774 \uae09\ubd80\uc0c1\ud558\uba70 \uc758\uc57d\ud488 \uad6c\ub9e4\uc758 \ud3b8\uc758\uc131\uacfc \uc811\uadfc\uc131\uc744 \ud601\uc2e0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \ud32c\ub370\ubbf9 \uc774\ud6c4 \ube44\ub300\uba74 \uc11c\ube44\uc2a4\uc5d0 \ub300\ud55c \uc218\uc694\uac00 \uc99d\uac00\ud558\uba74\uc11c \uc628\ub77c\uc778 \uc57d\uad6d\uc740 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uc758\uc57d\ud488 \uc720\ud1b5 \ubc0f \uacf5\uae09\ub9dd\uc5d0 \uc0c1\ub2f9\ud55c \ubcc0\ud654\ub97c \uac00\uc838\uc624\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc628\ub77c\uc778 \uc57d\uad6d\uc740 \ub354 \ub113\uc740 \uc9c0\uc5ed\uc5d0 \uac78\uccd0 \ub2e4\uc591\ud55c \uc81c\ud488\uc744 \uc81c\uacf5\ud558\uace0, \uac00\uaca9 \ube44\uad50\ub97c \uc6a9\uc774\ud558\uac8c \ud558\uba70, \ub9cc\uc131 \uc9c8\ud658 \ud658\uc790\ub4e4\uc5d0\uac8c \uc815\uae30\uc801\uc778 \uc758\uc57d\ud488 \ubc30\uc1a1 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud558\ub294 \ub4f1 \uc0c8\ub85c\uc6b4 \uac00\uce58\ub97c \ucc3d\ucd9c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ubcc0\ud654\ub294 \uc81c\uc57d\uc0ac\ub4e4\uc5d0\uac8c \uc720\ud1b5 \ucc44\ub110 \ub2e4\uac01\ud654\uc640 \ub514\uc9c0\ud138 \ub9c8\ucf00\ud305 \uc804\ub7b5\uc758 \uc911\uc694\uc131\uc744 \uac15\uc870\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc81c\uc57d \uc0b0\uc5c5 \ub0b4 \uc758\uc57d\ud488\uc758 \uc0b0\uc5c5\uc801 \uaddc\ubaa8 \uc0dd\uc0b0\uc778 \uc81c\uc57d \uc81c\uc870 \uc2dc\uc7a5\uc744 \uc2ec\uce35\uc801\uc73c\ub85c \ubd84\uc11d\ud569\ub2c8\ub2e4. \uc758\uc57d\ud488 \uc81c\uc870\ub294 \ubd84\uc1c4, \uacfc\ub9bd\ud654, \ucf54\ud305, \uc815\uc81c \uc555\ucd95 \ub4f1 \ub2e4\uc591\ud55c \ub2e8\uc704 \uacf5\uc815\uc73c\ub85c \uad6c\uc131\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd\uc5d0 \ub530\ub974\uba74, \uae00\ub85c\ubc8c \uc81c\uc57d \uc81c\uc870 \uc2dc\uc7a5\uc740 2031\ub144\uae4c\uc9c0 8,852.1\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc5d0 \ub3c4\ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 9.77%\ub97c \uae30\ub85d\ud560 \uc804\ub9dd\uc785\ub2c8\ub2e4. \ud2b9\ud788 \uce58\ub8cc \ubd84\uc57c \uc911\uc5d0\uc11c\ub294 \uc54c\uce20\ud558\uc774\uba38 \ud56d\uccb4 \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uac1c\ubc1c\uc5d0 \ud798\uc785\uc5b4 \uc2e0\uacbd\ud559 \uc81c\ud615\uc774 2031\ub144\uae4c\uc9c0 12.72%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\uc778\uc73c\ub85c\ub294 \uc8fc\uc694 \uc81c\uc57d\uc0ac\uc758 R&#038;D \ud22c\uc790 \uc99d\uac00, \uae30\uc874 \uc0dd\uc0b0 \ub77c\uc778\uc5d0 AI \uae30\ubc18 \uc790\ub3d9\ud654 \ud1b5\ud569, \uc8fc\uc694 \ud2b9\ud5c8 \ub9cc\ub8cc \ud6c4 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc2dc\uc7a5\uc758 \uae09\uc99d, API \uc0dd\uc0b0 \ub2a5\ub825\uc758 \ub9ac\uc1fc\uc5b4\ub9c1 \ubc0f \ud604\uc9c0\ud654, \uac1c\uc778 \ub9de\ucda4\ud615 \uc758\uc57d\ud488\uc744 \uc704\ud55c \ubd84\uc0b0\ud615 \ub9c8\uc774\ud06c\ub85c \ubc30\uce58 \ub77c\uc778 \ub3c4\uc785, \uadf8\ub9ac\uace0 \uc5f4 \ubc0f \uc6a9\ub9e4\ub97c \uc0ac\uc6a9\ud558\uc9c0 \uc54a\ub294 \uc815\uc81c 3D \ud504\ub9b0\ud305 \uae30\uc220 \ubc1c\uc804 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \uc5f0\uc18d \uc81c\uc870 \ub77c\uc778\uc740 \ucd9c\uc2dc \uc8fc\uae30\ub97c 30\uc77c\uc5d0\uc11c 5\uc77c \ubbf8\ub9cc\uc73c\ub85c \ub2e8\ucd95\ud558\uace0 \ub2e8\uc704\ub2f9 \ube44\uc6a9\uc744 \ucd5c\ub300 30% \uc808\uac10\ud558\uba70, FRAME \ud504\ub85c\uadf8\ub7a8\uc5d0 \ub530\ub77c FDA\uc758 \uc2e0\uc18d \uc2ec\uc0ac\ub97c \ubc1b\uc744 \uc218 \uc788\uc5b4 \uc8fc\ubaa9\ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc758 \uc0dd\uc0b0 \ub2a5\ub825 \ud655\uc7a5\uc740 \uc778\ub3c4\uc758 PLI \uc778\uc13c\ud2f0\ube0c, \uc911\uad6d\uc758 \ubc31\uc2e0 \ud604\uc9c0\ud654, \uc0bc\uc131\ubc14\uc774\uc624\ub85c\uc9c1\uc2a4\uc758 \ubc14\uc774\uc624\ub9ac\uc561\ud130 \uc99d\uc124 \ub4f1\uc5d0 \ud798\uc785\uc5b4 10.66%\uc758 \ub192\uc740 CAGR\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc804 \uc138\uacc4\uc801\uc778 \uc758\uc57d\ud488 \uac00\uaca9 \uc555\ubc15 \ubc0f \ube44\uc6a9 \uc808\uac10 \ub178\ub825, \ud575\uc2ec \uc6d0\ub8cc \uacf5\uae09\ub9dd\uc758 \ucde8\uc57d\uc131, GMP \ub4f1\uae09 \uc7ac\ud65c\uc6a9 \uc6a9\ub9e4 \ubd80\uc871, \uc5f0\uacb0\ub41c \uacf5\uc7a5\uc758 \uc0ac\uc774\ubc84 \ubcf4\uc548 \uc704\ud5d8 \ub4f1\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4. \uc758\uc57d\ud488 \uac00\uaca9 \uac1c\ud601(\uba54\ub514\ucf00\uc5b4 \ud611\uc0c1 \ubc0f EU HTA \uc9c0\uc5f0)\uc740 \ub9c8\uc9c4\uc744 \uc555\ubc15\ud558\uc5ec, \ucd08\uae30 \ud22c\uc790 \ube44\uc6a9\uc774 \ub192\uc74c\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \ube44\uc6a9 \ud6a8\uc728\uc801\uc778 \uc5f0\uc18d \ubc0f \uc77c\ud68c\uc6a9 \uc2dc\uc2a4\ud15c\uc73c\ub85c\uc758 \uc804\ud658\uc744 \uc720\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uaddc\uc81c \ud658\uacbd, \uae30\uc220 \uc804\ub9dd, \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778(\uacf5\uae09\uc790 \ubc0f \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825, \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611, \ub300\uccb4\uc7ac\uc758 \uc704\ud611, \uacbd\uc7c1 \uac15\ub3c4)\uc744 \ubd84\uc11d\ud558\uc5ec \uc2dc\uc7a5 \uc5ed\ud559\uc744 \uc2ec\uce35\uc801\uc73c\ub85c \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654\ub294 \ubd84\uc790 \uc720\ud615(\uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec, \uae30\uc874 \uc758\uc57d\ud488), \uc81c\uc870 \ubc29\uc2dd(\uc790\uccb4 \uc0dd\uc0b0, CMO\/CDMO), \uc81c\ud615(\uc815\uc81c, \ucea1\uc290, \uc8fc\uc0ac\uc81c, \uad6d\uc18c \ubc0f \uacbd\ud53c \uc81c\uc81c, \ube44\uac15 \ubc0f \ud3d0 \uc2a4\ud504\ub808\uc774 \ub4f1), \uc81c\uc870 \uae30\uc220(\ubc30\uce58, \uc5f0\uc18d, \uc77c\ud68c\uc6a9), \uc801\uc6a9 \ubd84\uc57c(\uc885\uc591\ud559, \ub2f9\ub1e8\ubcd1, \uc2ec\ud608\uad00, \uc2e0\uacbd\ud559, \ud638\ud761\uae30 \ub4f1), \ucc98\ubc29 \uc720\ud615(\ucc98\ubc29\uc57d, \uc77c\ubc18\uc758\uc57d\ud488) \ubc0f \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8 \ub4f1 \uc804 \uc138\uacc4 17\uac1c\uad6d \ud3ec\ud568)\ubcc4\ub85c \uc774\ub8e8\uc5b4\uc838 \uc2dc\uc7a5\uc758 \ub2e4\uac01\uc801\uc778 \uce21\uba74\uc744 \uc870\uba85\ud569\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc740 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d\uc744 \ud3ec\ud568\ud558\uba70, AbbVie, Amgen, AstraZeneca, BMS, GSK, Lilly, Lonza, Merck, Novartis, Pfizer, Roche, Sanofi \ub4f1 \uc8fc\uc694 \uae00\ub85c\ubc8c \uae30\uc5c5 19\uac1c\uc0ac\uc758 \uc0c1\uc138 \ud504\ub85c\ud544(\uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4, \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d \ub4f1)\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\ub9c8\uc9c0\ub9c9\uc73c\ub85c, \ubcf4\uace0\uc11c\ub294 \ubd84\uc0b0\ud615 \ub9c8\uc774\ud06c\ub85c \ubc30\uce58 \ubc0f 3D \ud504\ub9b0\ud305 \uc81c\ud615 \ud50c\ub7ab\ud3fc\uc774 \uac1c\uc778 \ub9de\ucda4\ud615 \uce58\ub8cc \ubc0f \ud658\uc790\ubcc4 \ud22c\uc5ec\ub97c \uac00\ub2a5\ud558\uac8c \ud558\uba70 \uc2dc\uc124 \uba74\uc801\uc744 \uc904\uc77c \uc218 \uc788\ub294 \uc0c8\ub85c\uc6b4 \uae30\ud68c\ub97c \uc81c\uacf5\ud558\ub294 \ub4f1 \uc2dc\uc7a5\uc758 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd, \ud2b9\ud788 \ubbf8\uac1c\ucc99 \ubd84\uc57c \ubc0f \ucda9\uc871\ub418\uc9c0 \uc54a\uc740 \uc694\uad6c \uc0ac\ud56d\uc5d0 \ub300\ud55c \ud3c9\uac00\ub97c \ud1b5\ud574 \ud5a5\ud6c4 \uc2dc\uc7a5\uc758 \ubc29\ud5a5\uc131\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-50012","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/50012"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=50012"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/50012\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=50012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=50012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=50012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}